Clinical Trials on 多发性骨髓瘤 in United Kingdom
总计6636个结果
-
University of LeedsKaryopharm Therapeutics Inc; Myeloma UK撤销
-
Oxford University Hospitals NHS TrustAmgen完全的
-
Chroma Therapeutics完全的
-
Acerta Pharma BVAcerta Pharma, LLC完全的
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)完全的
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)完全的
-
City of Hope Medical Center完全的
-
City of Hope Medical Center完全的I期多发性骨髓瘤 | II 期多发性骨髓瘤 | III 期多发性骨髓瘤 | 郁积型多发性骨髓瘤 | 难治性多发性骨髓瘤美国
-
Benovus Bio, Inc.未知骨髓增生异常综合征 (MDS) | 急性髓性白血病 (AML) | 多发性骨髓瘤 (MM) | 冒烟型多发性骨髓瘤 (sMM)美国
-
University of WashingtonNational Cancer Institute (NCI)终止
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的I期多发性骨髓瘤 | II 期多发性骨髓瘤 | III 期多发性骨髓瘤 | 难治性多发性骨髓瘤美国
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)终止I期多发性骨髓瘤 | II 期多发性骨髓瘤 | III 期多发性骨髓瘤 | 难治性多发性骨髓瘤美国
-
National Cancer Institute (NCI)完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
Mayo Clinic完全的
-
Mayo ClinicNational Cancer Institute (NCI)撤销I期多发性骨髓瘤 | II 期多发性骨髓瘤 | III 期多发性骨髓瘤 | 难治性多发性骨髓瘤美国
-
Institut de Recherches Internationales ServierADIR, a Servier Group company完全的复发或难治性多发性骨髓瘤 | 复发或难治性急性髓性白血病 | 复发或难治性非霍奇金淋巴瘤 | 复发或难治性慢性淋巴细胞白血病英国, 西班牙, 法国, 澳大利亚
-
NYU Langone HealthNational Cancer Institute (NCI)终止
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; Amgen未知
-
National Cancer Institute (NCI)完全的
-
Amgen主动,不招人
-
University of SouthamptonNIHR Clinical Research Facility, University Hospital Southampton NHS Foundation Trust; European... 和其他合作者终止
-
Ohio State University Comprehensive Cancer Center完全的
-
Janssen Research & Development, LLC批准上市
-
Sidney Kimmel Cancer Center at Thomas Jefferson...完全的
-
National Cancer Institute (NCI)完全的
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; Cancer Research UK; National Institute for Health Research...完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene Corporation终止
-
National Cancer Institute (NCI)完全的
-
Novartis Pharmaceuticals主动,不招人急性髓系白血病 (AML) | 多发性骨髓瘤 (MM) | 非霍奇金淋巴瘤 (NHL)比利时, 意大利, 大韩民国, 香港, 以色列, 芬兰, 西班牙, 日本, 美国
-
National Cancer Institute (NCI)主动,不招人
-
National Cancer Institute (NCI)完全的
-
Sheffield Teaching Hospitals NHS Foundation TrustNational Institute for Health Research, United Kingdom完全的